Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
KSQ Therapeutics is hoping to provide hope for ovarian and breast cancer patients that have developed a resistance to drugs and those who don’t respond at all by developing a drug that may be able to boost the effectiveness of PARP inhibitors such as Lynparza when used in combination with it, and the company has …
The Mayo Clinic Has discovered 4 gene alterations associated with increased risk of triple negative breast cancer, as published in the Journal of the National Cancer Institute. Having the ability to identify women with the inherited mutation in gene BRCA1 linked to this subtype of the disease who face highest risks for triple negative breast …